US5780587A
(en)
*
|
1990-08-24 |
1998-07-14 |
President And Fellows Of Harvard College |
Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
|
US6303567B1
(en)
*
|
1995-03-14 |
2001-10-16 |
Praecis Pharmaceuticals, Inc . |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
JPH11514333A
(ja)
*
|
1995-03-14 |
1999-12-07 |
プレーシス ファーマスーティカルズ インコーポレイテッド |
アミロイドの凝集の調節剤
|
US5948763A
(en)
|
1995-06-07 |
1999-09-07 |
New York University |
Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
|
US5985242A
(en)
*
|
1995-10-27 |
1999-11-16 |
Praecis Pharmaceuticals, Inc. |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
US6277826B1
(en)
*
|
1996-08-27 |
2001-08-21 |
Praecis Pharmaceuticals, Inc. |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
AU1072897A
(en)
|
1995-12-12 |
1997-07-03 |
Karolinska Innovations Ab |
Peptide binding the klvff-sequence of amyloid beta
|
EP0929574B1
(de)
*
|
1996-08-27 |
2005-06-29 |
Praecis Pharmaceuticals Incorporated |
beta-AMYLOID PEPTIDAGGREGATION REGULIERENDE PEPTIDE MIT D-AMINOSÄUREN
|
US6022859A
(en)
*
|
1996-11-15 |
2000-02-08 |
Wisconsin Alumni Research Foundation |
Inhibitors of β-amyloid toxicity
|
US6172043B1
(en)
*
|
1997-01-10 |
2001-01-09 |
Massachusetts Institute Of Technology |
Treatments for neurotoxicity in Alzheimer's disease caused by β amyloid peptides
|
US7045531B1
(en)
|
1997-03-11 |
2006-05-16 |
The General Hospital Corporation |
Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
|
CA2284170C
(en)
*
|
1997-03-11 |
2008-12-02 |
The General Hospital Corporation |
Identification of agents for use in the treatment of alzheimer's disease
|
DE19725619A1
(de)
*
|
1997-06-17 |
1998-12-24 |
Fraunhofer Ges Forschung |
Peptide als Agonisten und/oder Inhibitoren der Amyloidbildung und Zytotoxizität sowie der Verwendung bei Alzheimer'schen Krankheit, beim Typ II Diabetes mellitus und bei spongiformen Encephalopathien
|
EP1001987B1
(de)
|
1997-08-01 |
2010-12-15 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Zusammensetzung und verfahren zum nachweis von krankheiten in zusammenhang mit der bildung von amyloid-ähnlichen fibrillen oder protein-aggregaten
|
EP1005654B1
(de)
|
1997-08-01 |
2006-04-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten
|
EP1003539A4
(de)
|
1997-08-14 |
2002-09-11 |
Univ California |
FLUORESZIERENDE AMYLOID A beta PEPTIDE UND DEREN VERWENDUNG
|
US6703015B1
(en)
*
|
1999-09-03 |
2004-03-09 |
Ramot At Tel-Aviv University Ltd. |
Filamentous bacteriophage displaying an β-amyloid epitope
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US6710226B1
(en)
|
1997-12-02 |
2004-03-23 |
Neuralab Limited |
Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
US6787523B1
(en)
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
US6923964B1
(en)
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
US7799535B1
(en)
*
|
1997-12-09 |
2010-09-21 |
Arch Development Corporation |
Methods for identifying factors that control the folding of amyloid proteins of diverse origin
|
WO1999041279A2
(en)
*
|
1998-02-13 |
1999-08-19 |
Arch Development Corporation |
Methods and compositions comprising the use of blocked b-amyloid peptide
|
US6323218B1
(en)
|
1998-03-11 |
2001-11-27 |
The General Hospital Corporation |
Agents for use in the treatment of Alzheimer's disease
|
US6638711B1
(en)
|
1999-04-29 |
2003-10-28 |
The General Hospital Corporation |
Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
|
US6211149B1
(en)
*
|
1998-08-03 |
2001-04-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors of formation of protease resistant prion protein
|
US20030147882A1
(en)
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
US7122620B1
(en)
*
|
1998-05-27 |
2006-10-17 |
Medical Research Services And Development Ltd. |
Haptotactic peptides
|
AU781292B2
(en)
|
1999-03-04 |
2005-05-12 |
Praecis Pharmaceuticals Incorporated |
Modulators of beta-amyloid peptide aggregation comprising D-amino acids
|
EP1870419A3
(de)
*
|
1999-03-04 |
2008-01-02 |
Praecis Pharmaceuticals Incorporated |
Modulatoren der Beta-Amyloid-Peptid-Aggregation mit D-Aminosäuren
|
EP1173480B1
(de)
*
|
1999-05-05 |
2008-01-16 |
Neurochem (International) Limited |
Stereoselektive antifibrillogene peptide
|
US7060670B1
(en)
*
|
1999-05-05 |
2006-06-13 |
Neurochem (International) Limited |
Stereoselective antifibrillogenic peptides and peptidomimetics thereof
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
UA81216C2
(en)
*
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
US7569660B1
(en)
|
1999-06-09 |
2009-08-04 |
The University Of Chicago |
Recombinant prion-like proteins and materials comprising same
|
AUPQ180499A0
(en)
*
|
1999-07-23 |
1999-08-19 |
Biomolecular Research Institute Limited |
Beta-amyloid peptide inhibitors
|
WO2001006989A2
(en)
*
|
1999-07-27 |
2001-02-01 |
Abgenix, Inc. |
Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
|
GB9917725D0
(en)
*
|
1999-07-28 |
1999-09-29 |
Medical Res Council |
Peptides
|
GB9917724D0
(en)
*
|
1999-07-28 |
1999-09-29 |
Medical Res Council |
Peptides
|
JP2003506411A
(ja)
*
|
1999-08-09 |
2003-02-18 |
トリペップ アクチ ボラゲット |
タンパク質重合阻害剤および使用方法
|
CN1437442A
(zh)
*
|
1999-11-05 |
2003-08-20 |
阿克松尼克斯公司 |
适于体内应用治疗与折叠成淀粉样蛋白、淀粉样蛋白样沉积物的异常蛋白或其富含β-折叠的致病性前体有关的疾病的肽类似物和模拟物
|
US6689753B1
(en)
*
|
1999-11-05 |
2004-02-10 |
Axonyx, Inc. |
β sheet breaker peptide analogs that inhibit β pleated sheet formation in amyloid β-peptide
|
US20070135337A2
(en)
*
|
1999-11-29 |
2007-06-14 |
Neurochem (International) Limited |
Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases
|
US20020094335A1
(en)
*
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
CA2398567A1
(en)
*
|
2000-02-11 |
2001-08-16 |
Praecis Pharmaceuticals Incorporated |
Methods for enhancing the bioavailability of a drug
|
BR0108566A
(pt)
*
|
2000-02-21 |
2002-11-19 |
Pharmexa As |
Método para a regulação negativa in vivo de proteìna amilóide em um animal, incluindo um ser humano e para o tratamento e/ou prevenção e/ou melhora da doença de alzheimer ou outras doenças e condições cartacterizadas por depósitos de amilóide, análogo de um polipeptìdeo amiloidogênico,composição imunogênica, fragmento de ácido nucleico, vetor, célula transformada, composição para induzir a produção de anticorpos contra um polipeptìdeo amiloidogênico, linhagem celular estável, métodos para a preparação de uma célula, para a identificação de um polipeptìdeo amiloidogênico modificado, e para preparação de uma composição imunogênica, uso de um polipeptìdeo amiloidogênico ou de uma subsequência do mesmo, e, uso de um análogo de um polipeptìdeo amiloidogênico
|
AU783144B2
(en)
*
|
2000-02-21 |
2005-09-29 |
H. Lundbeck A/S |
Novel method for down-regulation of amyloid
|
US6835750B1
(en)
|
2000-05-01 |
2004-12-28 |
Accera, Inc. |
Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
|
US20070179197A1
(en)
*
|
2000-05-01 |
2007-08-02 |
Accera, Inc. |
Compositions and methods for improving or preserving brain function
|
DK1292294T3
(da)
*
|
2000-05-01 |
2009-06-22 |
Accera Inc |
Anvendelse af mediumkæde-triglycerider til behandling og forebyggelse af Alzheimers sygdom
|
EP2082749A3
(de)
|
2000-07-07 |
2010-06-30 |
Bioarctic Neuroscience AB |
Vorbeugung und Behandlung für Morbus Alzheimer
|
AU2007200047B2
(en)
*
|
2000-07-07 |
2009-11-26 |
Bioarctic Neuroscience Ab |
Prevention and treatment of Alzheimer's disease
|
US6472436B1
(en)
*
|
2000-07-17 |
2002-10-29 |
The Salk Institute For Biological Studies |
Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production
|
US20030044413A1
(en)
*
|
2000-08-15 |
2003-03-06 |
Regents Of The University Of Minnesota |
Methods of limiting apoptosis of cells
|
EP1538163A3
(de)
*
|
2000-11-01 |
2005-06-15 |
Insight Biotechnology Limited |
Phophoryliert Amyloid-Beta 1-43 Proteine und deren Verwendung bei der Behandlung der Alzheimer Krankheit
|
GB0028710D0
(en)
*
|
2000-11-24 |
2001-01-10 |
Isis Innovation |
Mixed fibrils
|
US20020133001A1
(en)
*
|
2000-11-27 |
2002-09-19 |
Praecis Pharmaceuticals Inc. |
Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
PE20020574A1
(es)
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
DE10101430B4
(de)
*
|
2001-01-13 |
2008-10-02 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Lösliche cyclische Analoga zur Modulation der Amyloidogenese
|
US7320793B2
(en)
|
2001-01-19 |
2008-01-22 |
Cytos Biotechnology Ag |
Molecular antigen array
|
WO2002074931A2
(en)
*
|
2001-03-20 |
2002-09-26 |
University Of Chicago |
Inhibitors and disassemblers of fibrillogenesis
|
JP2002346015A
(ja)
*
|
2001-05-28 |
2002-12-03 |
Hiroaki Yoshiike |
スイング診断装置
|
MXPA03011000A
(es)
*
|
2001-05-31 |
2004-02-27 |
Arete Associates |
Metodo de sensor de proteinas deformadas.
|
US7179784B2
(en)
*
|
2001-07-10 |
2007-02-20 |
Massachusetts Institute Of Technology |
Surfactant peptide nanostructures, and uses thereof
|
MY144532A
(en)
*
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
US6593455B2
(en)
*
|
2001-08-24 |
2003-07-15 |
Tripep Ab |
Tripeptide amides that block viral infectivity and methods of use thereof
|
US20030082191A1
(en)
*
|
2001-08-29 |
2003-05-01 |
Poduslo Joseph F. |
Treatment for central nervous system disorders
|
CA2460819A1
(en)
*
|
2001-09-18 |
2003-03-27 |
Affinium Pharmaceuticals, Inc. |
Methods and apparatuses for purification
|
EP1436317A1
(de)
*
|
2001-09-19 |
2004-07-14 |
Tripep Ab |
Moleküle, die die virale infektivität hemmen, und verfahren zu deren anwendung
|
US20040038861A1
(en)
*
|
2001-11-26 |
2004-02-26 |
Cooper Garth J. S. |
Methods and compositions for normalizing lipid levels in mammalian tissues
|
WO2003051374A2
(en)
*
|
2001-12-17 |
2003-06-26 |
New York State Office Of Mental Health |
SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
|
US20060057107A1
(en)
*
|
2001-12-21 |
2006-03-16 |
Shaked Ze Ev |
Combination treatment for multiple sclerosis
|
US20030186946A1
(en)
*
|
2002-01-29 |
2003-10-02 |
Cooper Garth James Smith |
Suppression of cytotoxic protein conformers
|
US20040052928A1
(en)
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
AU2004203461B2
(en)
*
|
2002-01-31 |
2009-09-03 |
Tel Aviv University Future Technology Development L.P. |
Peptides Antibodies Directed Thereagainst and Methods Using Same for Diagnosing and Treating Amyloid-Associated Diseases
|
EP1820806A1
(de)
*
|
2006-02-16 |
2007-08-22 |
Crossbeta Biosciences B.V. |
Affinitätsbereiche
|
TW200416037A
(en)
*
|
2002-02-20 |
2004-09-01 |
Kanegafuchi Chemical Ind |
Process for producing hydrophobic glycyrrhiza extract with high qualities
|
US20050079526A1
(en)
*
|
2002-02-20 |
2005-04-14 |
Affinium Pharmaceuticals, Inc. |
Methods and apparatuses for characterizing refolding and aggregation of biological molecules
|
AU2003247276A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Affinium Pharmaceuticals, Inc. |
Methods and apparatuses for characterizing stability of biological molecules
|
ATE478666T1
(de)
|
2002-03-01 |
2010-09-15 |
Takeda Pharmaceutical |
Antidepressivum
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
JP2006510572A
(ja)
*
|
2002-03-22 |
2006-03-30 |
エモリー ユニバーシティー |
自己組織化ペプチド主体の構造体および当該構造体の自己組織化を制御する方法
|
WO2003087834A2
(en)
*
|
2002-04-08 |
2003-10-23 |
Affinium Pharmaceuticals, Inc. |
High throughput analysis of recombinant proteins in multi-well plates
|
US6846640B2
(en)
*
|
2002-04-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40
|
DE10221052A1
(de)
*
|
2002-05-10 |
2003-12-04 |
Transmit Technologietransfer |
Wirkstoffe zu Therapie, Diagnostik und Prophylaxe von Erkrankungen, bei denen abnorme Proteinstrukturen auftreten
|
EP1380290A1
(de)
|
2002-07-09 |
2004-01-14 |
Universitair Medisch Centrum Utrecht |
Cross-Beta-Strukturweg und seine therapeutische Relevanz
|
US20070003552A1
(en)
*
|
2002-07-09 |
2007-01-04 |
Gebbink Martijn F B |
Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation
|
CA2487528A1
(en)
*
|
2002-07-24 |
2004-02-12 |
Innogenetics N.V. |
Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
|
US20040121445A1
(en)
*
|
2002-07-31 |
2004-06-24 |
Fabien Marino |
Cell cultures
|
US7345022B2
(en)
|
2002-09-19 |
2008-03-18 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Anti-fibril peptides
|
JP2006518373A
(ja)
*
|
2003-02-21 |
2006-08-10 |
トリペップ アクチ ボラゲット |
Hiv複製を抑制するためのグリシンアミド誘導体
|
US20050096319A1
(en)
*
|
2003-02-21 |
2005-05-05 |
Balzarini Jan M.R. |
Identification of compounds that inhibit replication of human immunodeficiency virus
|
US20060189545A1
(en)
*
|
2003-03-06 |
2006-08-24 |
Henderson Samuel T |
Novel chemical entities and methods for their use in treatment of metabolic disorders
|
US7189694B2
(en)
*
|
2003-04-18 |
2007-03-13 |
University Of Florida Research Foundation, Inc. |
Inhibitors of autophosphorylation protein kinases
|
AU2004234076A1
(en)
*
|
2003-04-30 |
2004-11-11 |
Laboratoires Serono Sa |
Beta-amyloid inhibitors and use thereof
|
PE20050627A1
(es)
|
2003-05-30 |
2005-08-10 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
JP4888876B2
(ja)
*
|
2003-06-13 |
2012-02-29 |
田平 武 |
アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター
|
JP5137400B2
(ja)
*
|
2003-06-30 |
2013-02-06 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. |
アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法
|
JP4917889B2
(ja)
|
2003-09-25 |
2012-04-18 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. |
アミロイド関連疾患を処置するための組成物及びその使用方法
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
JP2008500275A
(ja)
*
|
2003-12-31 |
2008-01-10 |
セントカー・インコーポレーテツド |
N末端の遊離チオールを有する新規な組み換えタンパク質
|
PL1755661T3
(pl)
|
2004-05-12 |
2014-10-31 |
Brigham & Womens Hospital Inc |
Gelsolina do stosowania w leczeniu infekcji
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
WO2006020040A2
(en)
*
|
2004-07-16 |
2006-02-23 |
Trustees Of Tufts College |
Apolipoprotein a1 mimetics and uses thereof
|
US20060057671A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Orser Cindy S |
Immobilized probes and methods of detecting conformationally altered prion proteins
|
US7161443B2
(en)
*
|
2004-09-30 |
2007-01-09 |
Broadcom Corporation |
Temperature compensated crystal oscillator
|
JP2008523815A
(ja)
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミテッド |
認知の改善における使用のためのヒト化アミロイドβ抗体
|
WO2006066049A2
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
US20090202980A1
(en)
*
|
2005-03-21 |
2009-08-13 |
Crossbeta Biosciences B.V. |
Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation
|
US9335331B2
(en)
*
|
2005-04-11 |
2016-05-10 |
Cornell Research Foundation, Inc. |
Multiplexed biomarkers for monitoring the Alzheimer's disease state of a subject
|
US20060252775A1
(en)
*
|
2005-05-03 |
2006-11-09 |
Henderson Samuel T |
Methods for reducing levels of disease associated proteins
|
US20070135376A1
(en)
*
|
2005-06-20 |
2007-06-14 |
Accera, Inc. |
Method to reduce oxidative damage and improve mitochondrial efficiency
|
EP1910844B1
(de)
*
|
2005-07-13 |
2012-04-18 |
Crossbeta Biosciences B.V. |
Cross-beta-struktur-bindende verbindungen
|
US8114832B2
(en)
*
|
2005-07-13 |
2012-02-14 |
Crossbeta Biosciences B.V. |
Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
|
US20080118529A1
(en)
*
|
2005-07-13 |
2008-05-22 |
Gebbink Martijn Frans Ben Gera |
Adjuvation Through Cross -Beta Structure
|
US7812025B2
(en)
|
2005-08-12 |
2010-10-12 |
Takeda Pharmaceutical Company Limited |
Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder
|
EP1951750A4
(de)
*
|
2005-11-10 |
2009-12-09 |
Roskamp Res Llc |
Modulation der angiogenese durch a-beta-peptidfragmente
|
US20100130416A1
(en)
*
|
2005-11-10 |
2010-05-27 |
Archer Pharmaceuticals, Inc. |
Modulation of angiogenesis by a-beta peptide fragments
|
KR101667623B1
(ko)
|
2005-11-30 |
2016-10-19 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
EP2808032B1
(de)
|
2005-12-12 |
2018-08-01 |
AC Immune S.A. |
A beta spezifische monoklonale antikörper mit therapeutischen eigenschaften
|
JP5888832B2
(ja)
*
|
2005-12-22 |
2016-03-22 |
フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー(ヴェーイーベー・ヴェーゼットウェー)Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw(Vib Vzw) |
タンパク質干渉を媒介する手段および方法
|
WO2007071789A1
(en)
*
|
2005-12-22 |
2007-06-28 |
Vib Vzw |
Means and methods for mediating protein interference
|
US8669418B2
(en)
|
2005-12-22 |
2014-03-11 |
Vib Vzw |
Means and methods for mediating protein interference
|
WO2007109056A2
(en)
|
2006-03-15 |
2007-09-27 |
The Brigham And Women's Hospital, Inc. |
Use of gelsolin to diagnose and treat inflammatory diseases
|
CA2630344C
(en)
|
2006-03-23 |
2015-04-28 |
Bioarctic Neuroscience Ab |
Improved protofibril selective antibodies and the use thereof
|
HUE035852T2
(en)
|
2006-04-03 |
2018-05-28 |
Accera Inc |
Use of ketogen compounds to treat memory decline
|
TWI334784B
(en)
*
|
2006-04-14 |
2010-12-21 |
Buck Inst For Age Res |
Compositions and methods for suppression of amyloid plaque formation associated with neurodegenerative disorders
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
JP5190957B2
(ja)
*
|
2006-04-28 |
2013-04-24 |
国立大学法人 鹿児島大学 |
アミロイドβ線維化阻害ペプチド
|
US8673579B2
(en)
*
|
2006-07-28 |
2014-03-18 |
Adlyfe, Inc. |
Peptide probes for diagnostics and therapeutics
|
US8188046B2
(en)
*
|
2006-10-16 |
2012-05-29 |
University Of South Florida |
Amyloid beta peptides and methods of use
|
WO2008099210A2
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
US7618944B2
(en)
*
|
2007-03-01 |
2009-11-17 |
Intezyne Technologies, Inc. |
Encapsulated amyloid-beta peptides
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
CN104083752B
(zh)
*
|
2007-06-27 |
2018-04-10 |
里兰斯坦福初级大学理事会 |
寡肽酪氨酸酶抑制剂及其应用
|
JP5568008B2
(ja)
*
|
2007-06-27 |
2014-08-06 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
ペプチドチロシナーゼインヒビターおよびその使用
|
WO2009005783A1
(en)
*
|
2007-06-28 |
2009-01-08 |
Blanchette Rockefeller Neurosciences Institute |
Peptides, compositions and methods for reducing beta-amyloid-mediated apoptosis
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
ES2556535T3
(es)
|
2007-07-31 |
2016-01-18 |
Accera, Inc. |
Uso de ensayo genómico y compuestos cetogénicos para tratamiento de una función cognitiva reducida
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
WO2009059239A2
(en)
*
|
2007-11-02 |
2009-05-07 |
Mayo Foundation For Medical Education And Research |
REDUCING Aβ42 LEVELS AND Aβ AGGREGATION
|
EP2058001A1
(de)
*
|
2007-11-08 |
2009-05-13 |
Crossbeta Biosciences B.V. |
Steigerung der Immunogenizität von Antigenen
|
EP2058000A1
(de)
*
|
2007-11-08 |
2009-05-13 |
Crossbeta Biosciences B.V. |
Zur Aktivierung von T-Zellen fähige immunogene Zusammensetzung
|
EP2250280B1
(de)
|
2008-01-25 |
2014-12-03 |
The General Hospital Corporation |
Therapeutische verwendungen von gelsolin bei nierenversagen
|
JP2011517282A
(ja)
*
|
2008-02-29 |
2011-06-02 |
バクスター・インターナショナル・インコーポレイテッド |
静注免疫グロブリン(IVIG)のinvitro抗アミロイドβ活性
|
US8105809B2
(en)
*
|
2008-07-03 |
2012-01-31 |
Accera, Inc. |
Enzymatic synthesis of acetoacetate esters and derivatives
|
CN102105071A
(zh)
*
|
2008-07-03 |
2011-06-22 |
艾克塞拉公司 |
用于治疗神经性障碍的乙酰乙酸的单甘油酯及其衍生物
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
CA2751679C
(en)
|
2009-02-06 |
2018-02-27 |
Women & Infants' Hospital Of Rhode Island |
Compositions for treating preeclampsia-type disorders of pregnancy comprising transthyretin
|
UA107657C2
(uk)
|
2009-03-10 |
2015-02-10 |
Такеда Фармасьютікал Компані Лімітед |
Похідні бензофурану
|
US9023767B2
(en)
*
|
2009-05-07 |
2015-05-05 |
Memorial Sloan-Kettering Cancer Center |
γ-Secretase substrates and methods of use
|
JP5554528B2
(ja)
*
|
2009-09-08 |
2014-07-23 |
国立大学法人 岡山大学 |
新規アミロイドβ凝集体結合性ペプチドおよび新規アミロイドβ凝集体結合性ペプチドを用いたアミロイド病の検査方法
|
WO2012033831A2
(en)
|
2010-09-07 |
2012-03-15 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for gamma-secretase assay
|
PE20140239A1
(es)
|
2010-10-07 |
2014-03-07 |
Takeda Pharmaceutical |
Derivados de 1,4-oxazepano
|
BR112013012033A2
(pt)
|
2010-11-15 |
2016-08-09 |
Merz Pharma Gmbh & Co Kgaa |
análogos de dipeptídeos para o tratamento de condições associadas com a formação de fibrila amiloide
|
WO2013021353A1
(en)
|
2011-08-11 |
2013-02-14 |
Bar-Ilan University |
Surface modified proteinaceous spherical particles and uses thereof
|
UA115133C2
(uk)
|
2011-10-07 |
2017-09-25 |
Такеда Фармасьютікал Компані Лімітед |
Сполуки 1-арилкарбоніл-4-оксипіперидину, придатні для лікування нейродегенеративних захворювань
|
CN107652356A
(zh)
|
2012-04-05 |
2018-02-02 |
于利希研究中心有限公司 |
包含多价结合淀粉样β蛋白的D‑肽的聚合物及其应用
|
DE102012102998B4
(de)
*
|
2012-04-05 |
2013-12-05 |
Forschungszentrum Jülich GmbH |
Polymere, enthaltend multivalente Amyloid-Beta-bindende D-Peptide und deren Verwendung
|
WO2013150126A2
(de)
|
2012-04-05 |
2013-10-10 |
Forschungzentrum Jülich Gmbh |
Verfahren zur behandlung von blut, blutprodukten und organen
|
ES2685374T3
(es)
*
|
2012-04-26 |
2018-10-08 |
Amylex Pharmaceuticals, Inc. |
Nueva composición para la reducción extracorpórea de beta amiloides y procedimiento de producción de la misma
|
WO2014061676A1
(ja)
|
2012-10-16 |
2014-04-24 |
武田薬品工業株式会社 |
複素環化合物
|
AP2015008591A0
(en)
|
2012-12-11 |
2013-07-31 |
Takeda Pharmaceutical |
Heterocyclic compounds
|
JP5804463B2
(ja)
*
|
2012-12-27 |
2015-11-04 |
国立研究開発法人科学技術振興機構 |
環状ペプチド及びこれを含有する医薬
|
US20140280367A1
(en)
*
|
2013-03-14 |
2014-09-18 |
Sap Ag |
Silo-aware databases
|
US9624184B2
(en)
|
2013-04-04 |
2017-04-18 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
WO2014163161A1
(ja)
|
2013-04-04 |
2014-10-09 |
武田薬品工業株式会社 |
複素環化合物
|
DE102014003262A1
(de)
|
2014-03-12 |
2015-09-17 |
Forschungszentrum Jülich GmbH |
Amyloid-Beta-bindende Peptide und deren Verwendung für die Therapie und die Diagnose der Alzheimerschen Demenz
|
US10597696B2
(en)
|
2013-09-18 |
2020-03-24 |
University Of Notre Dame Du Lac |
Detection of Niemann-Pick disease comprising detection of lysozyme and cathepsins
|
JP6660877B2
(ja)
|
2013-09-26 |
2020-03-11 |
フォルシュングスツェントルム・ユーリッヒ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
アミロイド−β−結合性ペプチド、ならびにアルツハイマー型認知症の治療および診断のためのその使用
|
US9963443B2
(en)
|
2014-06-09 |
2018-05-08 |
Takeda Pharmaceutical Company Limited |
Radiolabeled compounds
|
SG11201610734RA
(en)
|
2014-07-10 |
2017-01-27 |
Bioarctic Neuroscience Ab |
IMPROVED Aß PROTOFIBRIL BINDING ANTIBODIES
|
GB201414038D0
(en)
*
|
2014-08-07 |
2014-09-24 |
Univ Sussex The |
Alzheimer's disease
|
US10774120B2
(en)
|
2015-11-09 |
2020-09-15 |
The University Of British Columbia |
Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
|
EP3374383A4
(de)
|
2015-11-09 |
2019-05-15 |
The University Of British Columbia |
Amyloid-beta-epitope und antikörper dagegen
|
UA122433C2
(uk)
|
2016-02-04 |
2020-11-10 |
Такеда Фармасьютікал Компані Лімітед |
Заміщена піперидинова сполука та її застосування
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
EP3594203B1
(de)
|
2017-03-08 |
2021-08-04 |
Takeda Pharmaceutical Company Limited |
Substituierte pyrrolidinverbindung und verwendung davon
|
WO2018206732A1
(en)
|
2017-05-09 |
2018-11-15 |
Vib Vzw |
Means and methods for treating bacterial infections
|
JP7114594B2
(ja)
|
2017-07-28 |
2022-08-08 |
武田薬品工業株式会社 |
複素環化合物
|
US11319286B2
(en)
|
2017-08-03 |
2022-05-03 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and application thereof
|
MA52214A
(fr)
|
2018-03-28 |
2021-04-21 |
Takeda Pharmaceuticals Co |
Composé hétérocyclique et son utilisation
|
JP7339250B2
(ja)
|
2018-06-29 |
2023-09-05 |
武田薬品工業株式会社 |
複素環化合物およびその用途
|
JPWO2020153414A1
(ja)
|
2019-01-24 |
2021-12-02 |
武田薬品工業株式会社 |
複素環化合物及びその用途
|
TW202110824A
(zh)
|
2019-05-24 |
2021-03-16 |
美商賽吉醫療公司 |
化合物、組合物及使用方法
|
AU2020347578A1
(en)
|
2019-09-13 |
2022-04-14 |
Takeda Pharmaceutical Company Limited |
Use of an orexin 2 receptor agonist for the treatment of excessive sleepiness
|
JP2022547711A
(ja)
|
2019-09-13 |
2022-11-15 |
武田薬品工業株式会社 |
ナルコレプシーの治療に使用するためのtak-925
|
JP2021050161A
(ja)
|
2019-09-25 |
2021-04-01 |
武田薬品工業株式会社 |
複素環化合物及びその用途
|
JP2023550654A
(ja)
|
2020-11-25 |
2023-12-04 |
セージ セラピューティクス, インコーポレイテッド |
神経変性障害の治療のためのcyp46a1阻害剤としての4-フルオロ-(4-(4-ベンジル)ピペリジン-1-イル)(2-(ピリミジン-4-イル)ピリジン-3-イル)メタノン誘導体および類似化合物
|
WO2022190060A1
(en)
|
2021-03-12 |
2022-09-15 |
Takeda Pharmaceutical Company Limited |
An orexin 2 receptor agonist for the treatment of an orexin-mediated disease or disorder
|
EP4313045A1
(de)
|
2021-04-02 |
2024-02-07 |
Takeda Pharmaceutical Company Limited |
Verwendung eines orexin-2-rezeptoragonisten zur wiederherstellung nach einer operation
|
WO2023090268A1
(ja)
|
2021-11-17 |
2023-05-25 |
武田薬品工業株式会社 |
細胞の製造方法
|